Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nassira Belmessabih
Observed names:
Belmessabih, Nassira,
N. Belmessabih
Institutions:
Centre hospitalier de l'Université Laval,
Université Laval,
Centre de recherche du CHU de Québec-Université Laval
Observed institutions:
Centre hospitalier de l'Université Laval,
Institut Pasteur d'Algérie,
Université Laval,
Centre de recherche du CHU de Québec-Université Laval,
Université de Montréal
ORCID:
0000-0001-9700-120X
Observed ORCID:
0000-0001-9700-120X
OpenAlex ID:
A5081461370
CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer
2022
·
Xiaoye Sang
, Nassira Belmessabih
, et al.
·
Cancers
·
14
PDF
Immortalization of primary sheep embryo kidney cells
2021
·
N. Seridi
, M. Hamidouche
, et al.
·
In Vitro Cellular & Developmental Biology - Animal
·
12
Time Course of COVID-19 Pandemic in Algeria: Retrospective Estimate of the Actual Burden
2020
·
Mohamed Hamidouche
, Nassira Belmessabih
·
Journal of Contemporary Studies in Epidemiology and Public Health
·
4
PDF
Capripoxvirus antibodies detection: Relationship between the two methods alpha and beta of virus neutralisation test
2018
·
Mohamed Hamidouche
, Nassira Belmessabih
, et al.
·
Open Veterinary Journal
·
1
PDF
Abstract P87: Combined therapy with CRIF1/CDK2 interface inhibitor and Taxol against Triple-Negative Breast Cancer
2025
·
Xiaoye Sang
, Nassira Belmessabih
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
31
H-index:
3
I10-index:
2
Year
Topic
Type